Michael Andrew Chambers Net Worth & Insider Trades

Michael Andrew Chambers - Director, Sarepta Therapeutics, Inc

As of September 15, 2022

What is Michael Andrew Chambers's Net Worth?

The current estimated net worth of Sarepta Therapeutics, Inc's Director, Michael Andrew Chambers, is estimated to be about $352.2K . Michael Andrew Chambers owns about 183,372 units of Sarepta Therapeutics, Inc common stock. In the last 4 months at Sarepta Therapeutics, Inc, Michael Andrew Chambers has sold an estimated value of $0 worth.

What is Michael Andrew Chambers's Past Insider Trading?

Michael Andrew Chambers's largest purchase order was 57,100 units , worth over $5.96M on September 15, 2022. In total, Michael Andrew Chambers has made about 3 transactions over 4 months of their time at Sarepta Therapeutics, Inc. Michael Andrew Chambers usually trades in June, September and August, with the busiest year in 2022.

Michael Andrew Chambers

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Michael Andrew Chambers's' Mailing Address?

  • Mailing address is 215 First Street Cambridge MA 02142 MA

Sarepta Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Douglas S. Ingram 2020 $669,250 - $17,222 $17,222 $17,222 $1,291,947
Douglas S. Ingram 2019 $650,000 - $5,822 $5,822 $5,822 $1,387,072
Douglas S. Ingram 2018 $650,000 - $5,822 $5,822 $5,822 $1,433,872
Ian M. Estepan 2020 $445,822 $434,986 $32,744 $32,744 $32,744 $5,177,681
Ian M. Estepan 2019 - - - - - -
Ian M. Estepan 2018 - - - - - -
Gilmore O'Neill, M.B., M.M.Sc. 2020 $583,277 $766,949 $15,500 $15,500 $15,500 $3,790,049
Gilmore O'Neill, M.B., M.M.Sc. 2019 $563,962 - $15,300 $15,300 $15,300 $5,168,110
Gilmore O'Neill, M.B., M.M.Sc. 2018 $310,962 $1,154,760 $2,050 $2,050 $2,050 $6,449,176
William Ciambrone 2020 $458,179 - $14,500 $14,500 $14,500 $679,938
William Ciambrone 2019 $51,346 - $1,000 $1,000 $1,000 $4,345,194
William Ciambrone 2018 - - - - - -
Louise Rodino-Klapac, Ph.D. 2020 $495,590 $766,949 $13,532 $13,532 $13,532 $7,269,509
Louise Rodino-Klapac, Ph.D. 2019 - - - - - -
Louise Rodino-Klapac, Ph.D. 2018 - - - - - -
Joseph Bratica 2020 $326,028 $237,525 $11,645 $11,645 $11,645 $911,887
Joseph Bratica 2019 - - - - - -
Joseph Bratica 2018 - - - - - -
Sandesh Mahatme 2020 $312,835 $766,949 $39,413 $39,413 $39,413 $3,364,021
Sandesh Mahatme 2019 $557,327 - $14,840 $14,840 $14,840 $5,161,209
Sandesh Mahatme 2018 $498,112 - $24,838 $24,838 $24,838 $4,219,084
David Tyronne Howton, Jr. 2020 $470,695 $1,050,929 $157,280 $157,280 $157,280 $5,703,078
David Tyronne Howton, Jr. 2019 $458,844 - $13,318 $13,318 $13,318 $4,196,622
David Tyronne Howton, Jr. 2018 $438,185 - $13,118 $13,118 $13,118 $3,129,375
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/873303/000156459021019631/srpt-def14a_20210603.htm

What are Sarepta Therapeutics, Inc's Past Insider Trades?

Sarepta Therapeutics, Inc's most recent insider trade came on November 21, 2022 by Stephen Mayo who sold 858 units worth $94.31K . In the last 10 years, insiders at Sarepta Therapeutics, Inc have sold an estimated value of $176.19M and bought an estimated value of $53.33M worth of shares. Insider trading is most common in March, with the busiest year in 2017. The most active traders at the company are Sandesh Mahatme, EVP,  David T Howton, EVP,  and Edward M. Kaye, Director .

Sarepta Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1